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In recent years chemical suppression of the immune response has been studied 
mainly  with  newly  isolated  antibiotics  and  other  newly  synthesized  anti- 
metabolites. But the predecessors to these studies began with two products of 
nineteenth century organic chemistry, mustard gas and salicylic acid. In 1921 
Hektoen and Corper (1)  described marked inhibition of the immune response 
by mustard  gas  (di-(chlorethyl)sulfide).  About  the  same  time  Swift  (2)  first 
observed inhibition of antibody production by salicylates. During World War II 
the intensive investigations of mustard gas and of nitrogen mustard derivatives 
yielded other alkylating agents which today are among the more useful immuno- 
suppressive  drugs.  However,  in  the  several  decades  following  Swift's report 
salicylate and its acetylated derivative, aspirin, were often found to have only 
slight or no effect on  the  immune response  (3,  4).  Since  1950  this family of 
aromatic compounds has largely been ignored in immunological investigations. 
In this report we have examined the effects of salicylic acid (2-hydroxybenzoic 
acid)  and  gentisic  acid  (2,5-dihydroxybenzoic  acid)  on  rabbit  lymph  node 
cultures and have observed pronounced inhibition  of the secondary antibody 
response initiated in this system, The inhibitory levels of these compounds in 
vitro are sufficiently low to invite reexamination of their use in vivo. 
Materials  and Methods 
The general procedures employed in these experiments have been described by Michaelides 
and Coons (5) and Ambrose (6). They are briefly as follows: Adult male rabbits received 
their primary stimulation to bovine serum albumin (BSA) and diphtheria toxoid (DT) in vivo 
by means of a saline solution of both antigens injected intracutaneously into the four footpads 
and two ears. Three to  12 months later the lymph nodes draining the injection sites were 
excised and cut into 1 mm cubes. These pooled fragments received a secondary stimulation 
in vitro by incubation for 2 hr in culture medium containing 0.5 mg/ml BSA and 5 LUml DT. 
Excess antigen was washed from the fragments by several rinses with  medium. Fourteen 
stimulated fragments were aligned in a Leighton tube, and a thin pad of glass wool was in- 
serted on top to hold them in place (see Fig. 1 in reference 7). Each tube received 1 ml of 
Eagle's Minimum Essential Medium supplemented with 5 additional amino acids (0.1 mM 
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States Public Health Service. A preliminary report was published in Federation Proceedings, 
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each of alanine, aspartic  acid, glycine, proline, and  serine), 0.S #g/ml vitamin  Bz2, 1.0/~M 
cortisol (Solu-Cortef, Upjohn), 0.5 unit/ml insulin  (Iletin, Lilly), 60 units/ml  penicillin G, 
and other substances described in the several experiments. The inclusion of 0.01 mg/ml phenol 
red in the medium allowed visual estimation of the pH in the culture tube to within  0.1-0.2 
unit. 
The cultures were kept stationary at 37°C for 18 to 21 days, during which time the culture 
fluids were replaced every 3 days in most experiments but every 2 days in one described below. 
The pH of the cultures was recorded before each medium change in all experiments but was 
also recorded daily in some.  The fluids  removed from each culture were immediately frozen 
in the alcohol-dry ice bath and stored at  --5°C. Antibody titers to BSA and  DT were sub- 
sequently measured by the hemagglutination method with tanned sheep erythrocytes (Stavit- 
sky's modification of the Boyden procedure (8)). 
Frequent adjustment  of the pH of the cultures became necessary in  some  experiments. 
Several simple techniques for this  adjustment  were devised which  took  advantage  of the 
bicarbonate in the medium. Fine adjustments of the pH were made by blowing into the culture 
tube for a few seconds  a small stream of 5% CO2 (to lower the pH) or a small stream of air 
(to flush out CO2 and thus raise the pH). A more vigorous method for raising the pH involved 
introducing into the tube a strip of chromatography paper (1.4 X  4 cm) previously moistened 
with 1 ~ NaOH but largely dried during autoclaving. This strip was inserted just far enough 
into the tube so that it could be stoppered, and was never allowed to slip down near the frag- 
ments. Within several minutes to an hour, depending on the moistness of the strip, it absorbed 
sufficient CCh from the atmosphere of the tube to raise the pit of the medium  by several 
tenths of a pH unit. The strip was removed when the pit had reached the desired level. 
In designing most experiments we assigned groups of 4 culture tubes to each variable. The 
average titers for each group's 7 medium changes  (on days 3, 6,  9, 12, 15, 18, and  21) were 
used to graph its antibody response and to compare this response with those of other groups. 
Such comparisons were made as follows: In the control group of cultures, whose medium con- 
tained no salicylate or other inhibitor, the sum of the average titers obtained in the 7 medium 
changes was used as the 100% reference response value. Sums similarly derived from other 
experimental groups were compared with this sum from the reference group, and the relative 
responses of these other groups were computed as percentage values. 
In many experiments the relative amount  of antibody produced after day 9 was deter- 
mined by comparing the sum of the average titers for the medium changes of days 12, 15, 18, 
and 21  with the sum  of the average titers for all 7 medium changes in that group.  Antibody 
accumulating in the medium during any 3 day period is largely produced during that interval. 
This conclusion was derived from experiments employing puromycin in this culture system 
and others involving pulse labeling of the antibody produced with C14-amino acids (9). 
ILES~'LTS 
Dose-Response Relationship for Salicylate Inhibitior~ of the Immune Response 
in  Vitro.--Inhibition  of  the  secondary  response  by  several  concentrations  of 
sodium salicylate is shown in Fig.  1. Each of the four curves drawn here repre- 
sents  the average response of a  group of quadruplicate  cultures maintained for 
21  days.  Changes  of medium  every 3rd  day  exposed  each  culture  anew  to  a 
standard  concentration  of salicylate--0.5,  1.0,  or 1.5 mM. In this experiment a 
level of 0.5 m~  (0.08 mg/ml) depressed  the average response  to 50 %  of that of 
the  untreated  control  group  of  cultures.  Higher  concentrations  reduced  the 
responses proportionately. CHARLES  TESCH AMBROSE  463 
The variation in salicylate inhibition encountered in this culture system is 
illustrated  in  Fig.  2,  which  summarizes anti-BSA  and  anti-DT responses  in 
lymph node cultures prepared from 6 rabbits. In each inhibition curve the 21- 
day responses permitted by the three standard concentrations of salicylate were 
plotted relative to the 100 %  control (untreated)  response of that experiment. 
At a  concentration of 0.5  m~ salicylate there was a  moderate spread of the 
average responses from 38%  to  73%,  but  at a  1.5  mM concentration  all re- 
sponses were depressed to  10%  or less.  This spread of responses at  the low 
salicylate concentration may reflect errors inherent in the assay procedure but 
also suggests secondary influences on the mechanism of this inhibition. Two such 
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Fro. 1. Inhibition by salieylate of the secondary antibody response in vitro. Rabbit lymph 
node cultures were maintained for 21 days in medium containing 0, 0.5, 1.0, or 1.5 mM sodium 
salicylate. There were 5 cultures in the untreated control group and 4 cultures in each of the 
other 3 salicylate-treated groups. HA, hemagglutination. 
influences which we have identified are the pH of the medium and its content 
of sodium bicarbonate. 
The Effect of pH on the Secondary Response and on Its Inhibition  by Salicylate. 
--The effect of pH on the secondary response alone was examined in 4 culture 
groups, each consisting of 6 or 7 cultures (Fig. 3 A). The pH of 3 groups was 
adjusted daily (or more often) to 6.9,  7.2, or 7.5. The pH of a fourth group was 
not adjusted,  and averaged 7.4 during  the 3-wk experiment; the response of 
this untreated group was highest of the 4 groups and was taken as the 100 % 
reference response in Fig. 3 A. While a pH around 7.4 is optimal for this culture 
system, good secondary responses also occur over the entire pH range of 6.9 to 
7.5. 
The effect of pH on salicylate inhibition is illustrated in Fig.  3 B. The two 
inhibition  curves  shown  here  were  derived  from  two  sets  of  cultures,  each 464  INHIBITION  0]~  ANTIBODY SYNTHESIS  BY  SALICYLATE 
composed of 4 groups of quadruplicate cultures whose pH was adjusted daily 
(or more often) to 7.0  or 7.5.  In each set different groups were incubated in 
medium containing 0, 0.5,  1.0, or 1.5 m~ salicylate. (In the 2 non-salicylate- 
treated control groups the response of the pH 7.0 group was 89 % of that of the 
pH 7.5 group. However, in computing the data for Fig. 3 B we used the average 
response of each control group as the 100% reference value for the 3 salicylate- 
treated groups maintained at the same pH). The two curves show that salicylate 
inhibition of the secondary response was much greater in those cultures grown 
in the more acid medium. 
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FzG. 2.  Dose-response curves for salicylate inhibition of the secondary antibody response 
in vitro. Each curve was derived from 4 groups of quadruplicate cultures maintained for 18 
or 21 days in medium containing 0, 0.5,  1.0, or 1.5 m_~ sodium salicylate. In each experiment 
the average response of the untreated control group of cultures was regarded as the 100% 
reference response for the other salicylate-treated groups in  that experiment. (Each dose- 
response curve in this figure summarizes data equivalent to that contained in Fig. 1.) The 11 
responses shown here were obtained in cultures prepared from 6 rabbits, 5 of which had been 
sensitized to both BSA and DT.  Curves drawn with open symbols (circles,  etc.) represent 
anti-BSA responses, and those with solid symbols anti-DT responses. CHARLES  TESCH  AMBROSE  465 
The explanation of this pH effect probably depends on the fact that salicylic 
acid,  like many  other  weak  acids,  penetrates  cells mainly  in  its  nonionized 
state (10). Salicylic acid has an ionization constant (pKo) of 3.00, from which it 
can  be calculated that  at pH  7.5  only 0.003%  is nonionized but  at pH  7.0 
around 0.01% is nonionized (ca. 3 times more). When the percentage responses 
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Fro. 3.  Influence of pH on the secondary response in vitro and on its inhibition by salicy- 
late. Each point is the combined  average of the anti-BSA and anti-DT responses produced 
concurrently by a culture group during this 18-day experiment. 
A. The 18-day responses in media maintained at different pH's. Each of the 4 groups was 
comprised of 6 or 7 cultures. The response at pH 7.4 was maximal and was taken as the 100% 
reference response in this figure. 
B. Dose-response curves for salicylate  inhibition in 2 sets of cultures maintained at pH 7.0 
or 7.5. Each set consisted of 4 groups of quadruplicate cultures; the medium of each group con- 
taiued 0, 0.5,  1.0, or 1.5 ham sodium salicylate. The average response of each group is plotted 
as a function of the total salicylate  concentration (in raM) present in the medium of that group. 
C.  Dose-response curves for salicylate inhibition at pH 7.0 and 7.5. The data of B have 
been replotted as a function of the concentration of nonionized salicylic  acid (in/z~) present 
in each medium. The horizontal arrows indicate the relative shift in the response curve of the 
pH 7.5 cultures resulting from this change in the abscissa. 
of the two curves drawn in Fig. 3 B  were replotted against the concentration of 
the nonionized salicylic acid present in each medium,  a  single curve emerged, 
as can be seen in Fig. 3  C. This result suggests that the intracellular salicylate 
concentrations in the pH  7.0  cultures were 3  times higher  than  those in  the 
corresponding pH 7.5 cultures, thus accounting for the greater inhibition at the 
lower pH. 
The Effect of Sodium Bicarbonate Concentration on the Secondary Response and 
on  Its Inhibition  by Salicylate.mThe medium of all the cultures shown in Fig. 3 466  INHIBITION  0]~  ANTIBODY  SYNTHESIS  BY  SALICYLATE 
contained 10 m~ sodium bicarbonate, but in several of the experiments shown 
in Fig. 2 we had used other levels of bicarbonate. Therefore, the effect of this 
variable on salicylate inhibition was next examined. 
Fig. 4 A shows the effect on the secondary response alone of levels of sodium 
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FIG. 4. Influence of NaHCOa concentration on the secondary response in vitro and on its 
inhibition by salicylate. Each point is the combined average of the anti-BSA and anti-DT 
responses produced concurrently by a group of quadruplicate  cultures  during this  18-day 
experiment. 
A. The 18-day responses in media having similar pH's but containing different concen- 
trations of NaHC08. The response in medium with 10 m~ NaI-IC03 was maximal and was 
taken as the 100% reference response for this figure. 
B.  Dose-response curves for salicylate inhibition  in 4 sets of quadruplicate cultures whose 
media contained 5, 10, or 20 m~ NaHCOs; the "20 mu (pure)" set of cultures was maintained 
in media containing EDTA-treated,  recrystallized NaHC03  (see "Results").  The average 
response of each group is plotted as a function of the total salicylate concentration (in mE) 
present in each medium. 
C.  Dose-response curves for salicylate inhibition in media containing  10 m.~ or 20 m.M 
(pure) NaHCOs. The data of B have been plotted  in terms of the concentrations of non- 
ionized salicylic acid (in/zM) present in each medium. The horizontal arrows show the  rela- 
tively small shift in the rightmost curve produced by this change in the abscissa. 
bicarbonate from 0  to 25 m~. The maximal average response was produced by 
cultures maintained in 10 mM bicarbonate and was taken as the 100 % reference 
response value here. When no bicarbonate was added to the medium, responses 
of less than 10% occurred; when 5 rnM bicarbonate was added, responses of less 
than 50 %  were supported. Levels of bicarbonate higher than 10 m~ supported 
less than maximal but nevertheless substantial responses.  (In preparing these CHARLES  TESCH  AMBROSE  467 
media  the  pH  was  adjusted  with  NaOH  freshly dissolved  in  boiled  water; 
no  other special precautions were taken  to  exclude trace amounts  of bicar- 
bonate.) 
Fig. 4 B  shows the effect on salicylate inhibition of three different sodium 
bicarbonate concentrations: 5,  10, and 20 m~,  as indicated on the curves. In 
each set of cultures the response of the non-salicylate-treated control group 
was taken as the 100% reference response for the 3 salicylate-treated groups 
supported  in  medium  with  the  same  bicarbonate  concentration.  Increasing 
bicarbonate levels in the media diminished the inhibition produced by a given 
amount of salicylate. For example, 1 m~ salicylate permitted only 15 %  and 
21% responses in the 5 m~ and 10 m~ bicarbonate groups, respectively, but 
permitted 52% and 62% responses in the 20 m~ bicarbonate groups. Three 
possible explanations for this bicarbonate effect are next considered. 
Since salicylate forms stable chelates with Fe  +++, A1  +++, and Cu  ++ (11), we 
investigated  whether  increasing levels of bicarbonate  effectively inactivated 
more salicylate through its chelation with heavy metal cations contaminating 
the impure NaIICO~.  Sodium bicarbonate was treated with a  chelating agent 
(disodium  ethylenediaminetetraacetate,  or  EDTA)  to  remove  trace  heavy 
metals and then was recrystallized from water 3 times. This purified material 
was used in preparing the medium for cultures designated in Fig. 4 B  as "20 
m~ (pure)." Salicylate inactivation by chelation is not likely according to Fig. 
4  B,  since the three salicylate levels are even less inhibitory in the medium 
with  the 20 mM purified NaHCO3 than in medium with the 20 ra~ regular 
NaHC03. 
The second explanation entertained for the bicarbonate effect was the more 
alkaline pH of media containing the higher bicarbonate levels. We could not 
keep the pH identical in all sets of cultures, but did determine from a record of 
their daily pH's that the average 18-day pH values were 7.3-7.4 for the 5 m~ 
NaHCO3 set of cultures, 7.5 for the 10 rn~ and 20 m~r (pure) NaHCO8 sets, and 
7.6 for the other 20 m~ NaI-ICO3 set. The divergence of these inhibition curves 
in Fig. 4 B  was not corrected by taking into account the effect of pH on the 
levels of the nonionized salicylic acid.  This is illustrated in  Fig.  4  C,  which 
shows the inhibition curves of the 10 n~  and 20 m~ (pure) NaHCO3 sets of 
cultures plotted against the concentration of nonionized salicylic acid in their 
media. These curves are only slightly less divergent than they are in Fig. 4 B. 
This suggests that some factor other than mere pH of the culture medium is 
responsible for the reduced salicylate inhibition accompanying high bicarbonate 
levels. 
The  third  explanation  considered for  the  bicarbonate  effect was  the  in- 
creased Na  + level paralleling the increased NaHCO3 concentration. Previously, 
Trowell  (12)  had  observed that  rat lymphocytes survive longer  in medium 
containing  102  m~ Na  +  than  in medium  containing  the more conventional 468  INIIIBITION  OF  ANTIBODY SYNTHESIS  BY  SALICYLATE 
Na  +  level of 138  n~.  Fig.  5  A  shows that  the secondary response in rabbit 
lymph node cultures is maximal in medium containing around 123 m~ Na  + and 
is less than optimal in our usual medium containing 137 rn~ Na+. The inclusion 
of 20 ra~ NaHCOa raises the Na  + content by 15 % to 157 rr~. (The Na  + added 
to the medium by 0.3  to 1.3 m~ sodium salicylate and by 1.0 rn~  phosphate 
buffer was regarded as relatively insignificant and is ignored in this discussion.) 
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F1o. 5. Influence of NaCI concentration on the secondary  antibody response  in vitro and of 
Na  + concentration on salicylate inhibition of this response.  Each point in these figures is the 
combined average of the anti-BSA and anti-DT responses produced concurrently by quadru- 
plicate cultures during this 18-day  experiment. 
A.  The secondary antibody responses  in media containing different concentrations of NaC1. 
In each of the three separate experiments represented here the 100% reference response was 
that produced by the group whose medium contained 123 m~t NaC1. 
]3.  Dose-response curves for salicylate inhibition of cultures maintained in  media with 
different NaHCOa and total Na  + concentrations. The media of different sets of cultures con- 
tained 5 m~s or 20 m~x NaHCO8  and 123 m~ or 137 m~ NaC]; the total Na  + levels in these 
media were 143, 157, or 142 m*x (see ' Results"). 
Fig. 5 B shows salicylate inhibition curves from 3 sets of cultures whose media 
differed only as follows: (a) 5 m~ NaI-ICOa -4-  137 rnM NaC1  =  142 rma total 
Na+;  (b)  20 m~ NaHCO8 -4-  137 m~ NaCI  =  157 rr~ total Na+; and (c) 20 
m~ NaHCO3 4- 123 n~  NaC1 =  143 mM total Na  +. Inspection of Fig. 5 B will 
show that reduced salicylate inhibition depends on the NaHCO3 concentration 
in the medium and not on the total Na  + level. 
The Effect  of Cortisol  Concentration  on Salicylate  Inhibition  of the  Immune 
Response.--The similar effects of silicylates and corficosteroids on inflammation 
and on certain other aspects of metabolism have raised the question  whether CHARLES  TESCH  AMBROSE  469 
part of the clinical response to salicylate is mediated through the pituitary- 
adrenal system. Indeed, large doses of salicylate have been shown to produce 
elevated levels of adrenocortical hormones in man and in experimental animals 
(see review by Done et al.  (13)). Therefore, we considered whether inhibition 
by salicylate of the secondary response in vitro is influenced by the cortisol 
level in the culture medium. 
A  previous publication  (6)  described the requirement for corfisol in  sup- 
porting the secondary response in vitro. In serum-free medium physiological 
levels of cortisol,  or similar  corficosteroids, are  essential;  good antibody re- 
sponses are supported over the entire range of 0.01  to 10/zM corfisol. Table I 
presents data from one experiment in which control cultures supported by 0.01, 
TABLE I 
The Failure of Elevated Cortisd Levels to Influeme Salir,  ylate Inhibition  of 
the Secondary Antibody Response in Vitro 
Groups of quadruplicate cultures were maintained for 18 days in media containing differ- 
ent concentrations of cortisol and saiicylate. Concurrent anti-BSA and anti-DT  titers were 
measured and the  18-day responses of each group computed relative to  100% reference 
responses of the control group supported by 1.0 ~  cortisol but not exposed to salicylate. 
Cortisol concentration  0m): ....... 
nlM 
Salicylate concentration: 
None 
1.0 
1.5 
Anti-BSA response 
0.01  1.0  10.0 
%  %  % 
98  I00  I00 
15  20  14 
2  --  5 
Anti-DT response 
0.01  1.0 
%  % 
105  100 
9  8 
1 
10.0 
% 
93 
10 
2 
1.0, or 10 V~ cortisol produced nearly identical 18-day antibody responses (e.g., 
anti-BSA responses of 98 %,  100 %, and 100 % respectively). In other cultures 
supported  by  these  three  cortisol  concentrations,  treatment  with  1.0  mM 
sodium salicylate inhibited the average response of each group to very similar 
degrees (e.g., permitted only 15 %, 20 %, and 14 % of the corresponding maximal 
anti-BSA responses). Thus salicylate inhibition is not significantly affected by a 
1000-fold elevation in the cortisol concentration. 
Inhibition of the Immune Response by Aspirin and Gentisic Ac/d.--The effect 
on this culture system of many compounds structurally related to salicylic acid 
will be described in a subsequent publication (14). But two compounds warrant 
preliminary discussion here:  (a)  acetylsalicylic acid  (aspirin)  because it was 
frequently used in early clinical attempts to suppress the immune response, and 
(b)  gentisic acid (5-hydroxysalicylic acid) because it was considered by some 
investigators to be the active metabolic product of salicylic acid (15,  16). 470  INHIBITION  OF  ANTIBODY  SYNTHESIS  BY  SALICYLATE 
Equimolar  concentrations  of aspirin  and  sodium  salicylate  produce  nearly 
identical  inhibition,  as  shown  in  Fig.  6  A.  Hydrolysis  of  the  acetyl  group 
undoubtedly  occurs  in  the  lymph node  fragment  cultures,  converting  aspirin 
to free salicylic acid  (see "Discussion"). 
A normal metabolite of salicylic acid is its 5-hydroxy derivative, gentisic acid. 
Fig. 6 B illustrates the relative inhibition of the secondary response produced in 
three  experiments  by  eqnimolar  concentrations  of  gentisic  acid  and  sodium 
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FIG. 6. Inhibition of the secondary  antibody response in vitro by salicylate,  aspirin,  and 
gentisate.  Each point in these figures represents an average anti-B SA or anti-DT response pro- 
duced by quadruplicate  cultnres  during  18-day experiments. 
A.  Comparative inhibition  in one experiment  by equimolar  concentrations  of salicylate 
and aspirin.  The circles represent anti-BSA  responses; the squares  represent the concurrent 
anti-DT responses. 
B.  Comparative inhibition  in  two experiments  by salicylate  and  gentisate.  The circles 
represent the anti-BSA responses in one experiment;  the squares represent the anti-BSA and 
the triangles  the concurrent  anti-DT responses in another experiment. 
salicylate.  Suppression  of  the  response  to between  30%  and  40%  of the  un- 
treated  control  values was produced  by 1.0 m~t salicylate  and  by as little  as 
0.05 mM gentisic acid.  For more complete suppression gentisic acid was 3 times 
more  effective  than  equimolar  amounts  of salicylate.  This  greater  inhibitory 
activity of gentisic acid cannot be explained by the level of its nonionized form, 
since in equimolar solutions  at the  same pH  there  is 5  times more nonionized 
salicylic acid (pKa =  3.00) than gentisic acid (pK~ =  2.28). Preliminary experi- 
ments suggest  that cell penetration  by gentisic acid is not limited  to its non- 
ionized  form but  is more nearly  a  function  of the  total  concentration  of the 
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Because of the structural slmilaxity between salicylic and gentisic  acids and 
because of the latter's greater inhibitory effect, we also wondered whether the 
activity of salicylate in this culture system might be due to its oxidation to 
gentisic acid.  If such activity results entirely from this conversion,  then the 
inhibition produced by 1.0 m_~ sali.cylate (as in Fig. 6 B) implies an intraceUular 
level of gentisic acid equivalent to that produced by 0.1 m~ gentisic acid in the 
culture medium. In preliminary experiments we have chromatographed extracts 
of lymph node fragments incubated with C14-salicylic acid for various times. 
Extracts of media from such cultures have been examined  similarly.  As yet we 
have  not  found  significant  radioactivity  in  the  gentisic  acid  spot  of  these 
chromatograms above that due to trailing of the faster moving C14-salicylic  acid. 
The Effect of Salicylate Treatment at Different Stages of the Secondary Response 
Initiated in Vitro.--Cultures were incubated with an inhibitory level of salicy- 
late for different intervals during their 21-day life in order to determine whether 
the drug inhibits some step in the terminal synthesis of antibody (the produc- 
tive phase)  or whether it affects the complex sequence of reactions occurring 
between the introduction of an antigen to a primed cell and the start of antibody 
synthesis on ribosomes (the inductive phase). 
Typical of many experiments of this design is one illustrated in Fig. 7 A to H, 
in which  the culture medium contained 1.5 m~ sodium salicylate only for the 
intervals indicated by the cross-hatched bar at the top of each figure.  In the 
control group  (Fig.  7 A)  92%  of the antibody produced during  the 21-day 
experiment was synthesized after day 9. Treatment of other cultures throughout 
the 21 days with 1.5 rn~ salicylate (Fig.  7 E) depressed the response to 1% of 
the control group's average response.  In other culture groups salicylate treat- 
ment for only the first 3, 6, or 9 days lowered the response to 48 %, 27 %, and 
4%, respectively (see Fig.  7 B, C, and D). On the other hand, treatment with 
salicylate through day 21 starting on day 3, 6, or 9 depressed the response to 
10%, 13%, and 67%, respectively (see Fig. 7 F, G, and H). Thus a substantial 
response (67 %) occurred, although an inhibitory level of salicylate was intro- 
duced on day 9 and although most of the antibody in the control group (92 %) 
was produced after day 9. 
These data  suggest that  salicylate affects some step which occurs mainly 
during  the first 9 days of the secondary response initiated in vitro on day 0. 
This interval corresponds to what we regard as the inductive phase in these 
cultures. The same pattern of inhibition was obtained when an inhibitory level 
of gentisic acid was added toother cultures for different intervals during a 21-day 
experiment. Thus gentisic acid also exerts its inhibitory effect largely during the 
inductive phase in this culture system. 
Chloramphenicol  produces a similar pattern of inhibition,  illustrated in Fig. 8. 
In this experiment, treatment for 21 days with 100 ~  (40 ug/ml) chlorampheni- 
col depressed the response to 7 %  (Fig.  8 B) and with 1.25 mM salicylate de- 472  IN'ItlBITION O1  ~ ANTIBODY SYNTJtESIS BY  SALICYI..~T]~ 
pressed it to 2%  (Fig.  8 E).  When 100/~  chloramphenicol was added only 
during days 9 to 21 or days 12 to 21, the responses during these intervals were 
64%  and 78%,  respectively (Fig.  8  C  and D).  When  1.25 rr~ salicylate was 
present only during days 9 to 21 or days 12 to 21, the corresponding responses 
during these intervals were 47 % and 70 %  (Fig. 8 F and G). These two sets of 
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FIG. 7 A to H. Inhibition of the secondary  antibody response in cultures treated with 1.S 
m~ sodium salicylate for various intervals. Each figure shows the average anti-BSA response 
of a group of quadruplicate cultures over a 21-day  period. The period of salicylate treatment 
is indicated by the diagonally hatched bar at the top of each figure. The percentage value 
above each curve denotes the average 21-day response produced by that group relative to the 
100% response of the untreated control group in A. The percentage values under the curves 
of A and H indicate the average responses by those groups during days 9 to 21. 
values should be compared with 96 % and 82 %, the percentages of the untreated 
(control) responses produced during days 9 to 21 and days 12 to 21. Thus the 
addition of either compound to this culture system starting on day 9 or day 12 
depressed the subsequent response relatively little in view of the fact that most 
of the antibody was actually synthesized after day 9  (96%)  and after day 12 
(82 %). Although both compounds appear to inhibit processes occurring mainly 
during  the  inductive  phase,  their  modes  of  action  are  undoubtedly  quite 
different (17). 
The Temporal  Difference between Inhibition by Saticylate  and by 2,4-Dinitro- CHARLES  TESCHAMBROSE  473 
phenol.--One of several reported effects of salicylate on cellular  metabolism is 
the uncoupling of oxidative phosphorylation (18). We assumed that the second- 
ary response would be inhibited rather promptly by agents which interfere with 
energy  generation  when  added  late  in  the  response  during  the  productive 
phase as well as early during the inductive phase. But we concluded from the 
experiments described above that salicylate produced disproportionately little 
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FIG. 8 A to G.  Comparable inhibition of the secondary antibody response in vitro by 100 
/tu (40 ktg/ml) chloramphenicol (CA) and by 1.25 mm salicylate (SAL). Each figure depicts 
the average anti-BSA response of a group of quadruplicate cultures over a 21-day period. The 
period of chloramphenicol treatment is indicated by the stippled bars at the top of B, C, and 
D, and of salicylate treatment by the cross-hatched bars at the top of E, F, and G. The per- 
centage value aboz,  e each  curve denotes the average 21-day response produced by that group 
relative to the 100% response of the untreated control group in A. The percentage values 
under the curves denote average responses during days 9 to 21 or days  12 to 21, as indicated 
by the horizontal brackets. 
inhibition  when added on day 9 or later,  i.e.,  when the inductive phase has 
largely been completed. This discrepancy prompted us to study the standard 
uncoupling agent, 2,4-dinitrophenol (DNP). 
Fig. 9 A to I  compare the effects on antibody production when inhibitory 
levels of DNP, sodium salicylate, gentisic  acid,  and puromycin were added to 
different  cultures  of  the  same  experiment.  These  various  figures  show  the 
cumulative antibody production rather than amounts of antibody produced in 
each 3 day period (as in Figs. 1, 7, and 8). Fig. 9 A to D show that complete, or 
nearly complete, suppression of the response occurred when each inhibitor was 474  INHIBITION OF ANTIBODY SYNTIIESIS BY  SALICYLATE 
included in the medium from day 0  to day 18 at the concentration listed. The 
level of  puromycin used  (5  /~,  2.7  #g/ml)  is  several  times greater  than  is 
necessary for complete suppression, but the concentrations of the other three 
agents are quite near the minimum levels which suppress the response to less 
than 10%. 
Fig.  9  E  to I  show  the  control response and the responses when the four 
inhibitors were added  to other  cultures starting on day 8  (as indicated by a 
vertical arrow in each figure). The percentage values under the curves relate to 
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FIo. 9. Relative inhibition  of the secondary antibody response in vitro following the addi- 
tion of different inhibitors during the productive phase. Each figure represents the cumulative 
anti-BSA response of a group of 4 cultures whose medium was replaced every 2 days for 18 
days. The inhibitors and their concentrations tested are listed above the upper  row of figures; 
the duration of treatment with each inhibitor is indicated by a  characteristically shaded bar 
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A to D. Complete, or nearly complete, suppression of the response when the ~tbove  inhibi- 
tom were included in all medium changes throughout the 18-day experiment. The percentage 
values above these response curves were calculated relative to the 100% produced by the un- 
treated control group of cultures shown in E, the untreated control group of cultures. 
F to I. Average responses of cultures treated with one of the inhibitors starting on day 8 
(indicated by the vertical arrow) and continuing to day 18. The percentage values u~/er 
these curves represent the responses produced after day 8 relative to that produced by the 
control group of cultures after day 8. In the control group (E) 91% of the antibody produced 
during the 18 days was produced after day 8; this 91% was equated to 100% in computing 
the percentage values given under the curves in F to I. CHARLES  TESCH  AM~BROSE  475 
the amount of antibody produced by the control cultures from day 8 through 
day 18. The addition of an excess of puromycin on day 8 caused complete sup- 
pression of antibody synthesis within the next 2 days; the 7 % response produced 
after addition of this inhibitor probably represents  the small amount of pre- 
formed antibody present in the cells of these cultures. The addition of DNP on 
day 8 caused  suppression  of the subsequent response  to 32%  of the control 
value for days 8 to 18. On the other hand, the addition of equivalent inhibitory 
levels of salicylate or gentisate permitted 62%  and 56%,  respectively,  of the 
days 8 to 18 control response. These and similar data from other experiments 
indicate that DNP has an effect which differs temporally from that of salicylate 
or gentisate and thus suggest that DNP has a mode of action different  from that 
of the latter two compounds. 
DISCUSSION 1 
Reviews  concerning  salicylate  inhibition  of  the  immune  response  have 
recently been published  by Austen (3)  and by Schwartz  and Andr~  (4). In 
comparing  studies on salicylate inhibition in vivo  with our investigations in 
vitro we shall  consider initially (a)  the significance of total and non-protein- 
1  This discussion of experimental results must be prefaced by assurance that salicylate does 
not interfere with the assay procedure  itself,  since the drug has been reported  to  reduce 
specific precipitation in at least one immune system.  For example,  Coburu and Kapp  (19) 
added 1.32 mE sodium salicylate to a system of crystalline egg albumin and its antibody and 
observed that the precipitate was reduced by an amount equivalent to eliminating about half 
of the total antibody. In an identical system Friend (20) found that 2.0 n~ sodium salicylate 
caused a  54% reduction in the precipitation. However, Jager mad Nickerson (21)  incubated 
immune serum with 1.0 mg/ml salicylic acid  (7.25  n~)  for 18 hours at 37°C and found no 
decrease in typhoid O and H  agglutlnin titers. To insure that salicylate present in our culture 
media did not alter the hemagglutination titer directly, we carried out the following experi- 
ments. 
Sets of doubling dilutions of an immune serum to BSA were prepared, the final volume of 
each dilution being 0.5 ml. To each tube was added 0.3 ml of various sodium salicylate solutions 
such that the final concentration in each tube of a  set was 1, 2, 3, or 4 ra~. Control sets of 
dilutions with 0.3 ml normal saline (145 r~  NaCI) were also prepared. These sets were incu- 
bated at 37°C for 1 hr before 0.05 ml of 2% tanned sheep erythrocytes passively sensitized to 
BSA was added to each tube. The end points of these titrations were identical in all sets, in- 
dicating that salicylate at concentrations of 4 m~ or less in all dilutions of the immune serum 
had no effect on the assay. 
In another experiment, samples of the immune serum were diluted with equal volumes of 
sodium salicylate solutions such that the final concentration was 1, 2, 3, 6, or 25 mE. These 
salicylate-treated serum samples were incubated at 37°C  for 6  days in sterile sealed tubes 
and then individually fitrated. Again the end points were identical in all samples, indicating 
that the hemagglutinafion titration of immune serum was not depressed by prior incubation 
with as much as 25 m_~ salicylate. Similar experiments with serum-free tissue culture fluids 
containing antibody showed that incubation with salicylate did not reduce their hemagglutina- 
tion titers. The level of 25 n~ salicylate is 17 times greater than any used in the tissue culture 
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bound salicylate levels, (b) the inhibitory levels in vitro and in vivo, and (c) the 
time of effective administration of salicylate in both situations. 
The Relationship between in Vivo and in Vitro Levels.--The therapeutic activ- 
ity of salicylate is more accurately a function not of the total plasma concentra- 
tion but of the non-protein-bound  (free) salicylate level (22).  Salicylate is 50 
to 80 % bound to human plasma proteins, the percentage decreasing  with rising 
drug levels in the blood (23). In man the therapeutic range of total salicylate is 
30 to 50 mg/100 ml and is thus represented by levels of free salicylate between 
7.5 and 25 rag/100 ml (see Fig.  1 in reference 24). The tissue culture medium 
used in our experiments contained no serum or other proteins  except for 0.5 
unit/ml insulin  (ca. 22 #g/ml); and so the salicylate levels used in these cultures 
should properly be compared with the free salicylate levels in blood. Thus the 
tissue culture range of 0.5 to 1.5 ~  salicylate is equivalent to plasma levels of 
7 to 21 mg/100 ml free salicylate, or 30 to 50 rag/100 ml total salicylate. 
Inhibitory  Levels in  Vivo.--Jager and Nickerson  (21) found that  salicylate 
blood levels of 30  to 40 rag/100 ml reduced antibody production in human 
beings/mmunlzed with typhoid vaccine.  In rabbits serum levels between 20- 
30 mg/100 ml depressed precipitin production in experimentally induced serum 
disease (25). Similar results in rabbits were obtained by Smull et al.  (26). The 
highest level of salicylate which can safely be maintained in rabbits is reported 
to be 30 rag/100 ml (25, 26), or 7 rag/100 ml of free salicylate, ff we assume that 
binding in rabbit serum is quantitatively similar  to that in human serum.  If 
comparable degrees of immune inhibition are produced in vitro and in vivo by 
similar  levels of free salicylate, our data indicate that only partial suppression 
(20 to 60%) of the immune response would be obtained in rabbits. The further 
extrapolation of our data from rabbit lymph node cultures to human clinical 
studies suggests that more complete suppression  of the immune response might 
be obtained in clinical  situations,  since higher  salicylate blood levels are ap- 
parently tolerated in man than in rabbits. This conclusion is in keeping with the 
inhibition  described  in  Jager  and  Nickerson's  well  quantitated  study  (see 
Fig. 1 in reference 21). 
Time of Effective Salicylate Administration  in Vivo.--Our in vitro studies show 
that  salicylate inhibition  is  most  effective when  the  drug  is present  in  the 
culture medium during the inductive phase of the secondary response.  Many 
of the reported failures to inhibit the immune response in vivo with salicylate 
probably resulted from inadequate levels of the drug in the antibody-producing 
tissues during  the inductive phase.  For example,  in several negative clinical 
studies the antigenic stimulus dearly occurred long before salicylate treatment 
was begun, e.g., stimulation by Rh antigen during pregnancy (27) or stimula- 
tion by streptolysin during streptococcal pharyngitis (28). Analogously,  Perry 
(29) inoculated volunteers with typhoid vaccine who then took aspirin for the 
next 10 days; all developed agglutinins,  as might have been predicted. In con- CHARLES  TESCH  AMBROSE  477 
trast, Jager and Nickerson (21) administered salicylate to patients for 7 days or 
more before injecting typhoid vaccine; high plasma salicylate levels were main- 
tained for the next 2 wk with the resulting suppression of antibody formation 
to typhoid H  and O antigens.  Studies of immune suppression in experimental 
animals with various other inhibitors (30, 31) suggest the probable importance 
of priming animals or man with salicylate several days before antigen stimula- 
tion as well as maintaining maximally tolerated blood levels of the drug for a 
week or more afterwards. 
Inhibition by Aspirin.--Aspirin  has been used in several studies on immune 
suppression in man (29, 32). Mter its absorption from the internal tract aspirin 
is hydrolyzed in the tissues to salicylic  and acetic acids (33).  Such hydrolysis 
has been demonstrated in liver, kidney, and brain slices of rats (34) and upon 
incubation of aspirin with rat blood or thoracic duct lymph (35). Fig. 6 A shows 
that equimolar concentrations of aspirin and sodium salicylate produce nearly 
identical inhibition of the secondary response in vitro, suggesting  that hydroly- 
sis of aspirin occurs also in rabbit lymph node cultures. 
Inkibition by Gent~ic Acid.--Gentisic  acid is more effective than equimolar 
concentrations  of salicylic  acid by 3  to 20 times,  depending  on the level of 
inhibition  of the secondary response chosen  for comparison  (see  Fig.  6  B). 
(No analogous studies on immune suppression with gentisic acid in animals 
have been published.) The antirheumatic,  antipyretic, and analgesic  effects of 
gentisic acid have been reported as equal, and sometimes superior,  to those of 
salicylic acid (15, 36, 16). Because of their similar metabolic effects and related 
chemical structure and the fact that gentisic acid is a normal excretion product 
of salicylate (37), investigators have postulated that gentisic  acid is the active 
agent during salicylate treatment.  But this is doubtful for the several reasons 
discussed below. 
The biological oxidation of salicylate to gentisate was first studied by Lutwak- 
Mann (34), who reported that rats poisoned with white phosphorus or carbon 
tetrachloride and then given salicylate did not excrete gentisic acid.  She also 
found that incubation of liver pulp with salicylate produced a substance giving 
a color reaction typical of gentisic  acid. Although these observations suggested 
that oxidation occurs in the liver,  gentisic  acid has not been reported in the 
blood of salicylate-treated human subjects or experimental animals.  Meyer and 
Ragan  (15) did not detect gentisic  acid in the blood even of patients treated 
with sodium gentisate;  their assay could measure as little as 5 #g/ml  (0.005 
m~). This failure may indicate an extremely rapid renal dcarance of gentisic 
acid from the circulation,  since Batterman and Sommer (38) recovered in urine 
up to 84% of the gentisic  acid administered orally to patients.  Crabtree et al. 
(39) administered CX4-salicylic acid and C14-acetylsalicylic acid to normal and 
fevered rats and recovered C14-gentisic acid from kidney extracts and the urine 
of all rats and from the pituitary gland of the fevered rats. These authors related 478  INHIBITION  OF  ANTIBODY  SYNTKESIS  BY  SALICYLATE 
the latter finding to the antipyretic action of salicylate, but concluded that "the 
peripheral actions of salicylate are probably due to salicylate itself," since no 
widespread body distribution of any salicylate metabolite was found. 
To date we have failed to detect significant conversion of C14-1abeled salicylic 
acid to gentisic acid in our lymph node cultures. But the identification of any 
newly synthesized gentisic acid by conventional chromatography or  electro- 
phoresis is complicated by the fact that in both methods of separation the Rf 
values for genfisic acid are smaller than the corresponding values for salicylic 
acid (40, 39).  Thus the genfisic acid spot in either system of separation is fre- 
quently contaminated with trace amounts of the faster-migrating radioactive 
salicylic acid which trail behind. 
Arguments  against Salicylate's  Acting as an  Uncoupling Agent of Oxidative 
Phosphorylation  during  Immune  Suppression.--Experiments  were  described 
above in which the effect of an inhibitory level of 2,4-dinitrophenol (12-/~) was 
compared with that of comparable levels of salicylate (1.25 m~) and gentisate 
(0.5 rn~). These levels are "comparable" in the sense that they are the mini- 
mum values which when present from the start of the inductive phase suppress 
almost completely the in vitro response (i.e., permit less than 10% of the control 
response).  When these same levels were added on day 8 after the inductive 
phase was largely completed (Fig. 9 G and I), DNP inhibited antibody synthe- 
sis to a substantial degree, while salicylate and gentisate exerted considerably 
less inhibition. This quantitative difference in inhibition permits two possible 
interpretations: (a)  that salicylate and gentisate are weak uncouplers but that 
this culture system is more sensitive to their action during the inductive phase 
than during the later productive phase,  or  (b)  that salicylate and gentisate 
inhibit the immune response by some mechanism other than uncoupling oxida- 
tive phosphorylation. 
There are several additional reasons for rejecting the possibility that an un- 
coupling action is salicylate's mode of inhibiting the immune response. Brody 
(41) observed that gentisic acid did not uncouple oxidative phosphorylation in 
rat liver mitochondria under conditions where salicylate apparently did. Yet 
genfisic acid is an even more potent inhibitor of the immune response in vitro 
than is salicylate. Since these drugs are structurally similar and exert inhibitory 
effects on the immune response which are temporally alike, it seems unnecessary 
to postulate  two different modes of action.  And since gentisic acid fails to 
uncouple oxidative phosphorylation in mitochondrial preparations, some other 
mechanism common to the two drugs is possibly responsible for immune sup- 
pression in lymph node cultures. 
A final argument along the above lines stems from our observations that a 
5 ~  concentration of sodium sallcylate inhibits protein synthesis in Escherichia 
coli grown anaerobically as well as aerobically (42). Since oxidative phosphoryla- 
tion (respiration) is not part of the energy source for bacteria under anaerobic CHARLES  TESCH  AMBROSE  479 
conditions, salicylate must inhibit them by some mechanism other than un- 
coupling. 
Comparison  of the Effective Salicylate Level with that of other Inhibitors.--Be- 
cause relatively high levels of salicylate (500 to 1500 ~)  are necessary to sup- 
press the immune response in vitro, the mechanism of its action might appear 
less specific, and therefore less interesting, than that of other metabolic inhibi- 
tors which are active at much lower levels. For example, the secondary response 
in our culture system is suppressed 90% or more by 0.1 #m actinomycin D; by 
1.0  #M  puromycin,  cycloheximide,  or  mitomycin C;  by  10  ~  proflavine, 
acridine orange,  5-bromodeoxyuridine, or  2,4-dlnltrophenol; and by  100  V~ 
chloramphenicol or oxytetracycline (42). If the active form of salicylate is the 
nonionized acid and thus the effect of 1.5 nm total salicylate is due to the 
0.06 t~ salicylic acid present at pH 7.4, then this drug could be considered a 
relatively potent inhibitor of the immune response in vitro. 
SUVr~  ~RY 
Salicylate inhibition of the secondary antibody response initiated in vitro on 
day 0 has been studied in cultures of rabbit lymph node fragments. Levels of 
1.25 to 1.5 m_~ (0.20  to 0.24 mg/ml) sodium salicylate present in serum-free 
medium throughout an  18-  or  21-day culture period completely inhibit the 
secondary response. This inhibition is largely accomplished by the drug's action 
during the first 9 days, which corresponds to the inductive phase for this cul- 
ture system. Relatively little inhibition is produced by adding the drug only 
after day 9, although over 90% of the antibody produced during a  21-day ex- 
periment is synthesized after day 9. Studies with media of different pH's show 
that this inhibition is more correctly a function of the nonionized salicylic acid 
concentration in the medium than of the total salicylate concentrat on. Argu- 
ments are presented against the possibility that salicylate at the levels used 
here inhibits antibody synthesis by uncoupling oxidative phosphorylation. 
Acetylsalicylic acid (aspirin) produces the same degree of inhibition in vitro 
as  do  equimolar  concentrations of sodium salicylate.  Gentisate (5-hydroxy- 
salicylate) is 15-fold more effective in producing 50 % inhibition than salicylate; 
its temporal pattern of inhibition is similar to that of salicylate. 
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